Updates are available Correction dated 2024-03-06
Click to view Correction: https://doi.org/10.1038/s41591-024-02899-7
-
Authors
Ferrell, Marc
Wang, Zeneng http://orcid.org/0000-0002-6455-8228
Anderson, James T.
Li, Xinmin S. http://orcid.org/0000-0003-4946-4271
Witkowski, Marco http://orcid.org/0000-0002-6952-5038
DiDonato, Joseph A.
Hilser, James R.
Hartiala, Jaana A. http://orcid.org/0000-0003-4883-9318
Haghikia, Arash http://orcid.org/0000-0002-5646-3237
Cajka, Tomas http://orcid.org/0000-0002-9728-3355
Fiehn, Oliver http://orcid.org/0000-0002-6261-8928
Sangwan, Naseer http://orcid.org/0000-0002-2407-769X
Demuth, Ilja http://orcid.org/0000-0002-4340-2523
König, Maximilian
Steinhagen-Thiessen, Elisabeth
Landmesser, Ulf http://orcid.org/0000-0002-0214-3203
Tang, W. H. Wilson http://orcid.org/0000-0002-8335-735X
Allayee, Hooman http://orcid.org/0000-0002-2384-5239
Hazen, Stanley L. http://orcid.org/0000-0001-7124-6639
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 HL103866, P01 HL147823, T32 HL134622, T32 GM007250, P30ES007048, R01 HL133169, R01 HL148110)
Deutsche Forschungsgemeinschaft (WI 5229/1-1)
- License Information
-
More Information
Article History
Received: 16 March 2023
Accepted: 22 December 2023
First Online: 19 February 2024
Change Date: 6 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-02899-7
Competing interests
: S.L.H. and Z.W. report being named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S.L.H. and Z.W. also report having received royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab, a fully owned subsidiary of Quest Diagnostics, and Procter & Gamble. S.L.H. is a paid consultant for Zehna Therapeutics and Proctor & Gamble and has received research funds from Zehna Therapeutics, Proctor & Gamble, Pfizer and Roche Diagnostics. W.H.W.T. is a consultant for Sequana Medical A.V., Cardiol Therapeutics, Genomics plc, Zehna Therapeutics and Renovacor and has received honoraria from Springer Nature for authorship/editorship and from the American Board of Internal Medicine for exam writing committee service. All other authors declare no competing interests.
